Showing results (1171-1180 of 1,195) with videos related to

Sort By:
Pageof 120
Scientific Reports|October 6, 2015
Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in TaiwanYing-Ju Lin, Jeng-Sheng Chang, Xiang Liu, et al.
Plos One|April 6, 2012
Genome-wide association study of treatment refractory schizophrenia in Han ChineseYing-Jay Liou, Hui-Hung Wang, Ming-Ta Michael Lee, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Frontiers in Cardiovascular Medicine|August 26, 2022
First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarctionLien-Cheng Hsiao, Yen-Nien Lin, Woei-Cherng Shyu, et al.
Plos One|March 20, 2015
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanKuo-Hsuan Hsu, Chao-Chi Ho, Te-Chun Hsia, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Carcinogenesis|December 10, 2015
EGFR mutation and lobar location of lung adenocarcinomaChien-Hua Tseng, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Plos One|June 14, 2018
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2, Robert Allaway, Steve P Angus, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2025
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort studyTeng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Clinical and Molecular Hepatology|February 5, 2025
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort studyShou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Pageof 120